FABIO D’AGOSTINO

Venture Partner, Claris Ventures SGR

Fabio is a Venture Partner at Claris Ventures SGR, a VC firm focused on early stage investments in biopharma companies, where he brings over 10 years’ experience in both the medical device and the biopharmaceutical industry. He is currently also advising a number of early stage biotech companies in Europe, United States, Israel, South Korea. In 2013, he joined the Parenteral Drug Association (PDA) Cell and Gene Task Force (members include executives from GSK, Novartis, Lonza, Johnson & Johnson, Adaptimmune, Takeda, Bluebird Bio) with the aim to develop a manufacturing control strategy for cell and gene based medicinal products.

Fabio started his career at the medical device company Sorin Group (now LivaNova) after a BSc and a MSc with honours in Biomedical Engineering from the Polytechnic University of Turin (Italy). Later, he moved to Newcastle (UK) to take an Engineering Doctorate in Biopharmaceutical Process Development at Newcastle University. One of his main projects was the Multifactorial Analysis of Mesenchymal stem cell properties for storage and transportation